Interactions

Goldenseal And The Medicines It Touches

Of the eleven botanicals inside this blend, goldenseal has the clearest human findings attached to it. Almost none of them are about digestion. They are about what goldenseal does to the enzymes that clear other medicines, which makes it the one name on this panel worth raising before a first capsule.

By SodaMelt Team · Last updated November 4, 2026 · 8 min read · Interactions · Reviewed by Dr. Maureen Leonard, MD, MMSc

What goldenseal is, and why it is on this panel

Hydrastis canadensis is a woodland plant native to eastern North America, and the root is the part used. It carries berberine and related alkaloids, and it has a long history in traditional preparations for digestive and mucous membrane complaints.

The NCCIH summary is the plainest starting point on it, and the thing it is clearest about is how little good efficacy evidence exists for goldenseal on its own. That is not a criticism unique to this bottle; it is the state of the literature.

What goldenseal does have is a set of well-conducted human pharmacokinetic studies. Those studies are not about whether it helps digestion. They are about what happens to other drugs when somebody is taking it.

The enzyme finding, and why it matters

Cytochrome P450 3A, usually written CYP3A, is the enzyme system responsible for clearing a very large proportion of prescription medicines from the body. Slow it down and blood levels of those medicines rise; speed it up and they fall.

Gurley's controlled study gave healthy volunteers a standardised goldenseal supplement for fourteen days and probed CYP3A activity with midazolam at 8 mg. Goldenseal inhibited the enzyme in vivo. Kava kava, tested in the same design, did not, which is what makes the goldenseal result a finding rather than an artefact of the method.

Why in vivo is the word that matters

A great many herb and drug interactions are reported from laboratory glassware and never reproduce in people. This one was measured in people, over a realistic period of use, with a standard probe drug. That puts it in a much smaller category, and it is the reason this post exists rather than a paragraph on a safety page.

Four records about one botanical, and three of the four are about what it does to other medicines rather than what it does on its own.

The metformin study

A 2025 three-arm crossover study looked at the same botanical alongside metformin in adults with type 2 diabetes, and found the interaction depends on the metformin dose. The relative effect was larger at the lower dose.

That is an unusually practical result. It means the answer to whether this matters is not the same for two people on the same medicine, and it is exactly the sort of detail a prescriber can use and a label cannot express.

Three readings a non-specialist can take from it:

• An interaction that is dose-dependent is still an interaction.
• Being on a low dose of something is not automatically the safer position.
• The question belongs with the person who set the dose, because they know which direction matters.

Why a crossover design is worth knowing about

In a crossover study each participant takes each arm in turn, so every person is their own comparison. That removes a great deal of the noise that makes small herb studies hard to read, because the differences between individuals cancel out instead of piling up. Three arms means three conditions were compared in the same people rather than two.

It is a design chosen when investigators expect a real effect and want to measure its size rather than establish that it exists. That is a reasonable summary of where the goldenseal literature stands: the direction has been settled since the enzyme work, and the recent study was asking how much it matters and to whom.

The amount question, again

Everything above concerns goldenseal as studied. What this label prints is the name, the binomial Hydrastis canadensis and the word root, inside a 250 mg Proprietary Blend shared by 11 botanicals.

So the honest position is bounded rather than resolved. Goldenseal here cannot exceed 250 mg, and an even split would put it at 22.7 mg. Whether that is enough to reproduce a fourteen-day enzyme effect is not something the panel allows anybody to work out, and the studies used standardised supplement preparations rather than a share of a blend.

It is worth being precise about which direction the uncertainty runs. Nothing here establishes that a capsule of this blend will change how any medicine is cleared. What it establishes is that the ingredient with the documented effect is on the list, that the label gives nobody a figure to weigh, and that the studies used standardised preparations at amounts a blend of this size could not obviously supply.

That is a narrower statement than most safety copy makes, and it is the one the panel supports. A reader who takes only the headline away will over-worry; a reader who takes only the small print away will skip a question worth asking once.

Three named conversations on this panel

A safety section that hedges everything teaches a reader to skip it. This panel has three interactions worth naming specifically, and each has a human finding behind it.

Three named conversations rather than a general instruction to be careful. Each one has a specific human finding behind it.

The LactMed entry on goldenseal and the entry on alfalfa are the two most useful short references for a prescriber, and both are free. The third conversation, about the anthranoid herbs and potassium alongside a diuretic, is set out on the side effects page with its own sources.

What to actually do about it

1. Write down what you take, including anything bought without a prescription.
2. Take the bottle itself, or a photograph of the panel, rather than the brand name.
3. Ask specifically about CYP3A and about metformin if either applies to you, because naming the enzyme gets a better answer than asking whether a supplement is safe.
4. If you are on warfarin, ask about the alfalfa row as well, since vitamin K is the relevant point there.
5. Decide with that answer rather than before it.

None of that is unusual advice, and it is not specific to this bottle. What is specific is that this panel carries a botanical with a measured human enzyme effect, and that the panel does not say how much of it is in the capsule.

Four questions for any panel with goldenseal on it

• Is an amount printed for it, or is it inside a blend?
• Is the plant part named? Root is what the studies used.
• Does the seller mention any interaction at all, or does the subject only appear in general boilerplate?
• Does anything you already take get cleared by CYP3A, and do you know which of your medicines those are?

On this bottle the answers run: no amount, yes root, the subject appears in the label's general caution rather than by name, and the fourth is the one only your own prescriber can answer.

References